CCM alumnus holds endowed assistant conductor chair at Cincinnati Symphony Orchestra
The Cincinnati Business Courier and Cincinnati Magazine spotlight François López-Ferrer's career
The Cincinnati Symphony Orchestra recently announced that longtime donors Ashley and Barbara “Bobbie” Ford made a major gift to endow the orchestra’s assistant conductor chair, currently held by UC College-Conservatory of Music alumnus François López-Ferrer (BM Composition, ‘12).
As assistant conductor, López-Ferrer provides artistic support to CSO Music Director Louis Langrée and May Festival Principal Conductor Juanjo Mena throughout all rehearsals and performances. He also conducts the CSO Young Peoples Concerts, which reach over 17,000 students and teachers. Read more about the endowed chair in this Cincinnati Business Courier story.
François López-Ferrer. Photo/Cincinnati Symphony Orchestra
The Spanish-American conductor has a formidable musical legacy; his father, the late Jesús López-Cobos, served as Music Director of the CSO from 1986 to 2001 and as Music Director Emeritus until his passing in 2018. López-Ferrer, grew up in Cincinnati, attended CCM and has many ties to the local music community. Read more about López-Ferrer in this Q-and-A feature story by Cincinnati Magazine.
López-Ferrer founded Ensemble Vita, composed of fellow students from CCM, and led concerts throughout the Cincinnati area with innovative programming spanning Baroque through 21st-century repertoire. In 2012, he and fellow CCM alumnus Isaac Selya (DMA Orchestra Conducting, ‘14) co-founded the Queen City Chamber Opera. Now known as the Queen City Opera, its mission is to perform classical operas, featuring emerging artists, the highest artistic standards and a focus on contemporary issues. It is currently led by Artistic Director Selya and Associate Music Director Jesse Leong (BM Piano, '15; MM Orchestral Conducting, '17).
François López-Ferrer conducting. Photo/Cincinnati Symphony Orchestra
While studying composition at CCM, López-Ferrer’s teachers included Joel Hoffman, Miguel Roig-Francolí and Michael Fiday. He then studied conducting at the Lausanne Conservatory of Music and has since served as associate conductor of the National Symphony Orchestra of Chile and debuted with many orchestras across Europe and South America.
López-Ferrer recently garnered international attention following a critically acclaimed debut with the Verbier Festival Orchestra, filling in for Iván Fischer and conducting alongside Sir Simon Rattle and Gabor Takács-Nagy at the 2018 Verbier Festival in Switzerland. Highlights of the 20/21 season include debuts with the Spanish National Orchestra, the Symphony Orchestra of Galicia and the Buenos Aires Philharmonic at the esteemed Teatro Colón. He will also participate in the renowned Bruno Walter National Conductor Preview with the Louisiana Philharmonic Orchestra.
Featured image at top: Performance photo provided by Cincinnati Symphony Orchestra.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.